Fund · FPHAX · US registered fund
Select Pharmaceuticals Portfolio
Managed by Fidelity Select Portfolios. Net assets $1.52B at 28 Feb 2026.
Top 10 holdings
The 10 largest are 75.6% of net assets, out of 50 holdings
25.18%
ELI LILLY and CO · US
10.07%
GSK PLC · GB
7.53%
JOHNSON and JOHNSON · US
5.01%
UCB SA · BE
4.93%
ROCHE HOLDING AG · CH
4.93%
ASTRAZENECA PLC · GB
4.64%
GILEAD SCIENCES INC · US
4.59%
MERCK and CO INC · US
4.42%
4.26%
Fidelity Revere Street Trust · US
Source: SEC Form N-PORT, period ended 28 Feb 2026
The fund
- Category
- Mutual or closed-end fund
- Domicile
- United States
- Ticker
- FPHAX
- LEI
- MN21BN6DBQP38HPMPO32
Source: Official register
With a free account
A free account opens 10 full pages a month and lets you follow this page: every holding, changes since the last filing, country and sector exposure, country risk of the holdings, exports to Excel.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.